Skip to content
Topics
Breast Cancer
Chronic Lymphocytic Leukemia
Melanoma
Multiple Myeloma
Non-Small Cell Lung Cancer
Conference Coverage
ASCO 2026 Show Dailies
ASCO GI 2026 Conference Coverage
ASH 2025 Conference Coverage
JADPRO 2025 Conference Coverage
HCP Programs
Expert Perspectives in Bladder Cancers
Expert Perspectives in GI Cancers
Expert Perspectives in Multiple Myeloma
Expert Perspectives in NET
Expert Perspectives in RCC
GI Cancers Podcast
GI Cancer Webinar
Multiple Myeloma Roundtables
Patient Programs
Treatment Perspectives in Multiple Myeloma
Dialogues in Multiple Myeloma
FAQ Brochure: Multiple Myeloma
About
Advertise
Contact Us
Topics
Breast Cancer
Chronic Lymphocytic Leukemia
Melanoma
Multiple Myeloma
Non-Small Cell Lung Cancer
Conference Coverage
ASCO 2026 Show Dailies
ASCO GI 2026 Conference Coverage
ASH 2025 Conference Coverage
JADPRO 2025 Conference Coverage
HCP Programs
Expert Perspectives in Bladder Cancers
Expert Perspectives in GI Cancers
Expert Perspectives in Multiple Myeloma
Expert Perspectives in NET
Expert Perspectives in RCC
GI Cancers Podcast
GI Cancer Webinar
Multiple Myeloma Roundtables
Patient Programs
Treatment Perspectives in Multiple Myeloma
Dialogues in Multiple Myeloma
FAQ Brochure: Multiple Myeloma
About
Advertise
Contact Us
Subscribe
Gastrointestinal Cancers
tv_1_line
4 Podcasts
Listen on Spotify
All episodes from this series:
Jonathan Mizrahi, MD: Long-Term OS Outcomes Across Subgroups in the HIMALAYA Trial
Listen to Episode
Richard Kim, MD: Using Durvalumab + Gemcitabine-Cisplatin in Clinical Practice
Listen to Episode
Thomas Abrams, MD: Overall Survival Data From the HIMALAYA Trial
Listen to Episode
Dina Ioffe, MD: The Importance of Liver Function in Unresectable HCC
Listen to Episode
